ASGCT 2022
CRISPR-Cas9 RNP Editing of Primary T Cells Using the Flowfect® Transfection Technology Platform
DOWNLOAD PDF
ISCT 2022
CRISPR-Cas9 RNP editing of primary T cells using the Flowfect® transfection technology platform
BioRxiv 2021
Electro-mechanical transfection for non-viral primary immune cell engineering
ASGCT2020
Flowfect®: A scalable non-viral delivery process for T cell engineering
ISSCR 2020
Flowfect® Transfection of iPSCs Maintains Cell Pluripotency
Scientific Reports
Microfluidic screening of electric fields for electroporation
